Document Detail

Quality of Life after Ischemic Stroke Varies in Western Countries: Data from the Tinzaparin in Acute Ischaemic Stroke Trial (TAIST).
MedLine Citation:
PMID:  21388828     Owner:  NLM     Status:  Publisher    
Functional outcome after stroke varies significantly between countries. However, whether health-related quality of life (QoL) after stroke also differs between countries is unknown. TAIST was a randomised controlled trial assessing the safety and efficacy of tinzaparin versus aspirin in 1484 patients with acute ischaemic stroke across 11 countries. Countries were grouped into 5 geographic regions: British Isles (Ireland and UK), Franco (Belgium and France), North America (Canada), northwest Europe (Germany and The Netherlands), and Scandinavia (Denmark, Finland, Norway, and Sweden). QoL was measured at 6 months using the Short-Form 36 (SF-36) health survey. The relationship between region and QoL was assessed relative to the British Isles using linear regression adjusted for case mix, service quality variables, and treatment assignment. A total of 1220 survivors were included in this analysis. Significant differences in QoL were identified between countries and regions; northwest Europe rated their QoL highest in terms of physical functioning (20.3; 95% confidence interval [CI] 10.8-29.8), bodily pain (12.3; 95% CI, 2.7-22.0), and vitality (9.0; 95% CI, 1.1-16.9). Franco countries reported the lowest QoL for emotional role (-17.9; 95% CI, -32.6 to -3.3) and mental health (-11.2; 95% CI, -18.2 to -4.3). The British Isles rated QoL lowest for physical and social functioning. Our data indicate that QoL varies considerably among countries and regions, even when adjusted for prognostic case mix and care quality variables. How different case mixes and healthcare systems might contribute to these findings merits further investigation.
Nikola Sprigg; Laura J Gray; Philip M W Bath; Hanne Christensen; Peter Paul De Deyn; Didier Leys; Desmond O'Neill; E Bernd Ringelstein;
Related Documents :
19104228 - The design and interpretation of pilot trials in clinical research in critical care.
7897458 - Cost-effectiveness comparisons using "real world" randomized trials: the case of new an...
21249678 - Risperidone versus other atypical antipsychotics for schizophrenia.
14760438 - The number needed to harm: is it too optimistic?
24709018 - Disentangling sense of coherence and resilience in case of multiple traumas.
21042008 - Interventions aiming at balance confidence improvement in older adults: an updated review.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2011-3-8
Journal Detail:
Title:  Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association     Volume:  -     ISSN:  1532-8511     ISO Abbreviation:  -     Publication Date:  2011 Mar 
Date Detail:
Created Date:  2011-3-10     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9111633     Medline TA:  J Stroke Cerebrovasc Dis     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
Copyright © 2011 National Stroke Association. Published by Elsevier Inc. All rights reserved.
Institute of Neuroscience, University of Nottingham, Nottingham, UK.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Effects of paraspinal fatigue on lower extremity motoneuron excitability in individuals with a histo...
Next Document:  Modifications of the ABCD(2) Score Do Not Improve the Risk Stratification of Transient Ischemic Atta...